CIK 0001727196 · Non-accelerated filer
Scholar Rock Holding Corp
Sign in to watch- Ticker
- SRRK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 823750435
- Phone
- 857-259-3860
- Business address
- 301 BINNEY STREET, 3RD FLOOR, CAMBRIDGE, MA, 02142
- Open-market buys, last 90 days
- $11,999,922
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$11,999,922. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-13 | Woods Keith Chief Operating Officer | Sale | −16,746 | $42.70 | $715K | 583,254 |
| 2026-01-13 | Vaishnaw Akshay President of R&D | Sale | −20,438 | $42.70 | $873K | 595,767 |
| 2026-01-13 | Hallal David Chief Executive Officer | Sale | −57,450 | $42.70 | $2.5M | 1,541,645 |
| 2025-12-16 | Peng Katie Director | Sale 10b5-1 | −726 | $43.88 | $32K | 33,188 |
| 2025-12-16 | Peng Katie Director | Sale 10b5-1 | −280 | $44.63 | $12K | 32,908 |
| 2025-12-12 | AKKARAJU SRINIVAS Director | Option exercise | +1,064,804 | $7.35 | $7.8M | 6,367,614 |
| 2025-12-12 | AKKARAJU SRINIVAS Director | Option exercise · Warrants to Purchase Common Stock | −1,064,804 | 0 | ||
| 2025-12-11 | Invus Global Management, LLC 10% owner | Option exercise | +1,575,008 | $7.35 | $11.6M | 10,825,013 |
| 2025-12-11 | Invus Global Management, LLC 10% owner | Option exercise · Warrant (right to buy) | −1,575,008 | 0 | ||
| 2025-12-04 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Option exercise 10b5-1 | +65,625 | $26.05 | $1.7M | 174,589 |
| 2025-12-04 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Option exercise 10b5-1 | +21,093 | $18.08 | $381K | 195,682 |
| 2025-12-04 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Option exercise 10b5-1 | +5,607 | $4.86 | $27K | 201,289 |
| 2025-12-04 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Option exercise 10b5-1 | +1,281 | $7.62 | $10K | 202,570 |
| 2025-12-04 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Option exercise 10b5-1 | +11,250 | $10.00 | $113K | 213,820 |
| 2025-12-04 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Option exercise 10b5-1 | +23,571 | $15.75 | $371K | 237,391 |
| 2025-12-04 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Option exercise 10b5-1 | +8,035 | $35.15 | $282K | 245,426 |
| 2025-12-04 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Sale 10b5-1 | −136,462 | $45.21 | $6.2M | 108,964 |
| 2025-12-04 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −65,625 | 4,375 | ||
| 2025-12-04 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −21,093 | 1,407 | ||
| 2025-12-04 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,607 | 0 |
Page 5 of 12 · 227 trades